Lee AYY. The changing landscape of anticoagulation in cancer-associated thrombosis. Blood Adv. 2020;4(5):969.

Gelijkaardige items

• Pan D, Rampal R, Mascarenhaset J. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia. Blood Adv. 2020;4(5):970-982.
  Gepubliceerd in: (2020)
• Mullally A, Hood J, Harrison C, Mesa R. Fedratinib in myelofibrosis. Blood Adv. 2020;4(8):1792-1800.
  Gepubliceerd in: (2020)
• The changing landscape of anticoagulation in cancer-associated thrombosis
  door: Lee, Agnes Y. Y.
  Gepubliceerd in: (2020)
• Ediriwickrema A, Aleshin A, Reiter JG, et al. Single-cell mutational profiling enhances the clinical evaluation of AML MRD. Blood Adv. 2020;4(5):943-952.
  Gepubliceerd in: (2020)
• Brown LM, Lonsdale A, Zhu A, et al. The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia. Blood Adv. 2020;4(5):930-942.
  Gepubliceerd in: (2020)